1 | VWM1, VWM2, VWM3, VWM4, VWM5, EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
|
| Identification of ten novel mutations in patients with eIF2B-related disorders.
|
| Ohlenbusch A, Henneke M, Brockmann K, Goerg M, Hanefeld F, Kohlschutter A, Gartner J.
|
| Hum Mutat 25(4):411. 2005
|
2 | EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
|
| The life and death of oligodendrocytes in vanishing white matter disease.
|
| Van Haren K, van der Voorn JP, Peterson DR, van der Knaap MS, Powers JM.
|
| J Neuropathol Exp Neurol 63(6):618-30. 2004
|
3 | EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
|
| Mutations causing childhood ataxia with central nervous system hypomyelination reduce eukaryotic initiation factor 2B complex formation and activity.
|
| Richardson JP, Mohammad SS, Pavitt GD.
|
| Mol Cell Biol 24(6):2352-63. 2004
|
4 | EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
|
| Characterization of the mammalian initiation factor eIF2B complex as a GDP dissociation stimulator protein.
|
| Williams DD, Price NT, Loughlin AJ, Proud CG.
|
| J Biol Chem 276(27):24697-703. Epub 2001 Apr 25. 2001
|
5 | EIF2B1, EIF2B2, EIF2B3, EIF2B4, EIF2B5
|
| Identification of domains and residues within the epsilon subunit of eukaryotic translation initiation factor 2B (eIF2Bepsilon) required for guanine nucleotide exchange reveals a novel activation function promoted by eIF2B complex formation.
|
| Gomez E, Pavitt GD.
|
| Mol Cell Biol 20(11):3965-76. 2000
|
6 | EIF2B3
|
| Identification of eIF2Bgamma and eIF2gamma as cofactors of hepatitis C virusinternal ribosome entry site-mediated translation using a functional genomicsapproach.
|
| Kruger M, Beger C, Li QX, Welch PJ, Tritz R, Leavitt M, Barber JR,Wong-Staal F.
|
| Proc Natl Acad Sci U S A 97(15):8566-71. 2000
|